nodes	percent_of_prediction	percent_of_DWPC	metapath
Metipranolol—Uveitis—Azathioprine—systemic scleroderma	0.0359	0.0359	CcSEcCtD
Metipranolol—Lacrimation—Pentoxifylline—systemic scleroderma	0.0323	0.0323	CcSEcCtD
Metipranolol—Lacrimation increased—Pentoxifylline—systemic scleroderma	0.0206	0.0206	CcSEcCtD
Metipranolol—Blepharitis—Mycophenolate mofetil—systemic scleroderma	0.0145	0.0145	CcSEcCtD
Metipranolol—Angina pectoris—Pentoxifylline—systemic scleroderma	0.0116	0.0116	CcSEcCtD
Metipranolol—Conjunctivitis—Pentoxifylline—systemic scleroderma	0.0103	0.0103	CcSEcCtD
Metipranolol—Epistaxis—Pentoxifylline—systemic scleroderma	0.01	0.01	CcSEcCtD
Metipranolol—Bronchitis—Mometasone—systemic scleroderma	0.00988	0.00988	CcSEcCtD
Metipranolol—Abnormal vision—Mycophenolic acid—systemic scleroderma	0.00986	0.00986	CcSEcCtD
Metipranolol—Photophobia—Lisinopril—systemic scleroderma	0.00956	0.00956	CcSEcCtD
Metipranolol—Conjunctivitis—Mometasone—systemic scleroderma	0.0089	0.0089	CcSEcCtD
Metipranolol—Arthritis—Leflunomide—systemic scleroderma	0.00885	0.00885	CcSEcCtD
Metipranolol—Angina pectoris—Captopril—systemic scleroderma	0.00879	0.00879	CcSEcCtD
Metipranolol—Atrial fibrillation—Mycophenolic acid—systemic scleroderma	0.00866	0.00866	CcSEcCtD
Metipranolol—Epistaxis—Mometasone—systemic scleroderma	0.00864	0.00864	CcSEcCtD
Metipranolol—Arthritis—Mycophenolic acid—systemic scleroderma	0.00845	0.00845	CcSEcCtD
Metipranolol—Photophobia—Mycophenolate mofetil—systemic scleroderma	0.00838	0.00838	CcSEcCtD
Metipranolol—Rhinitis—Mometasone—systemic scleroderma	0.00824	0.00824	CcSEcCtD
Metipranolol—Tension—Pentoxifylline—systemic scleroderma	0.00814	0.00814	CcSEcCtD
Metipranolol—Nervousness—Pentoxifylline—systemic scleroderma	0.00806	0.00806	CcSEcCtD
Metipranolol—Vision blurred—Pentoxifylline—systemic scleroderma	0.00782	0.00782	CcSEcCtD
Metipranolol—Atrial fibrillation—Lisinopril—systemic scleroderma	0.0078	0.0078	CcSEcCtD
Metipranolol—Abnormal vision—Mycophenolate mofetil—systemic scleroderma	0.00778	0.00778	CcSEcCtD
Metipranolol—Arthritis—Lisinopril—systemic scleroderma	0.00761	0.00761	CcSEcCtD
Metipranolol—Palpitations—Pentoxifylline—systemic scleroderma	0.00733	0.00733	CcSEcCtD
Metipranolol—Angina pectoris—Leflunomide—systemic scleroderma	0.00724	0.00724	CcSEcCtD
Metipranolol—Rhinitis—Captopril—systemic scleroderma	0.00724	0.00724	CcSEcCtD
Metipranolol—Hypertension—Pentoxifylline—systemic scleroderma	0.00716	0.00716	CcSEcCtD
Metipranolol—Bronchitis—Leflunomide—systemic scleroderma	0.00715	0.00715	CcSEcCtD
Metipranolol—Myalgia—Pentoxifylline—systemic scleroderma	0.00706	0.00706	CcSEcCtD
Metipranolol—Anxiety—Pentoxifylline—systemic scleroderma	0.00704	0.00704	CcSEcCtD
Metipranolol—Discomfort—Pentoxifylline—systemic scleroderma	0.00698	0.00698	CcSEcCtD
Metipranolol—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.00691	0.00691	CcSEcCtD
Metipranolol—Atrial fibrillation—Mycophenolate mofetil—systemic scleroderma	0.00684	0.00684	CcSEcCtD
Metipranolol—Bronchitis—Mycophenolic acid—systemic scleroderma	0.00682	0.00682	CcSEcCtD
Metipranolol—Oedema—Pentoxifylline—systemic scleroderma	0.00677	0.00677	CcSEcCtD
Metipranolol—Conjunctivitis—Leflunomide—systemic scleroderma	0.00645	0.00645	CcSEcCtD
Metipranolol—Epistaxis—Leflunomide—systemic scleroderma	0.00625	0.00625	CcSEcCtD
Metipranolol—Cough—Mometasone—systemic scleroderma	0.00625	0.00625	CcSEcCtD
Metipranolol—Angina pectoris—Lisinopril—systemic scleroderma	0.00622	0.00622	CcSEcCtD
Metipranolol—Tension—Captopril—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Pentoxifylline—systemic scleroderma	0.00617	0.00617	CcSEcCtD
Metipranolol—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.00615	0.00615	CcSEcCtD
Metipranolol—Bronchitis—Lisinopril—systemic scleroderma	0.00615	0.00615	CcSEcCtD
Metipranolol—Nervousness—Captopril—systemic scleroderma	0.00611	0.00611	CcSEcCtD
Metipranolol—Myalgia—Mometasone—systemic scleroderma	0.00609	0.00609	CcSEcCtD
Metipranolol—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00604	0.00604	CcSEcCtD
Metipranolol—Somnolence—Pentoxifylline—systemic scleroderma	0.00602	0.00602	CcSEcCtD
Metipranolol—Rhinitis—Leflunomide—systemic scleroderma	0.00597	0.00597	CcSEcCtD
Metipranolol—Epistaxis—Mycophenolic acid—systemic scleroderma	0.00597	0.00597	CcSEcCtD
Metipranolol—Vision blurred—Captopril—systemic scleroderma	0.00593	0.00593	CcSEcCtD
Metipranolol—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00578	0.00578	CcSEcCtD
Metipranolol—Rhinitis—Mycophenolic acid—systemic scleroderma	0.00569	0.00569	CcSEcCtD
Metipranolol—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00562	0.00562	CcSEcCtD
Metipranolol—Myocardial infarction—Lisinopril—systemic scleroderma	0.00558	0.00558	CcSEcCtD
Metipranolol—Palpitations—Captopril—systemic scleroderma	0.00556	0.00556	CcSEcCtD
Metipranolol—Cough—Captopril—systemic scleroderma	0.00549	0.00549	CcSEcCtD
Metipranolol—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00547	0.00547	CcSEcCtD
Metipranolol—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Metipranolol—Bronchitis—Mycophenolate mofetil—systemic scleroderma	0.00538	0.00538	CcSEcCtD
Metipranolol—Epistaxis—Lisinopril—systemic scleroderma	0.00537	0.00537	CcSEcCtD
Metipranolol—Myalgia—Captopril—systemic scleroderma	0.00535	0.00535	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00532	0.00532	CcSEcCtD
Metipranolol—Discomfort—Captopril—systemic scleroderma	0.00529	0.00529	CcSEcCtD
Metipranolol—Dyspnoea—Mometasone—systemic scleroderma	0.00521	0.00521	CcSEcCtD
Metipranolol—Bradycardia—Lisinopril—systemic scleroderma	0.00521	0.00521	CcSEcCtD
Metipranolol—Rhinitis—Lisinopril—systemic scleroderma	0.00513	0.00513	CcSEcCtD
Metipranolol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Metipranolol—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00492	0.00492	CcSEcCtD
Metipranolol—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00489	0.00489	CcSEcCtD
Metipranolol—Vision blurred—Leflunomide—systemic scleroderma	0.00488	0.00488	CcSEcCtD
Metipranolol—Asthenia—Pentoxifylline—systemic scleroderma	0.00486	0.00486	CcSEcCtD
Metipranolol—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Metipranolol—Tension—Mycophenolic acid—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Metipranolol—Nervousness—Mycophenolic acid—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Metipranolol—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Metipranolol—Myalgia—Azathioprine—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Metipranolol—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00466	0.00466	CcSEcCtD
Metipranolol—Discomfort—Azathioprine—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Metipranolol—Palpitations—Leflunomide—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Metipranolol—Dyspnoea—Captopril—systemic scleroderma	0.00457	0.00457	CcSEcCtD
Metipranolol—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00456	0.00456	CcSEcCtD
Metipranolol—Somnolence—Captopril—systemic scleroderma	0.00456	0.00456	CcSEcCtD
Metipranolol—Cough—Leflunomide—systemic scleroderma	0.00452	0.00452	CcSEcCtD
Metipranolol—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.00449	0.00449	CcSEcCtD
Metipranolol—Dizziness—Pentoxifylline—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Metipranolol—Hypertension—Leflunomide—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Metipranolol—Myalgia—Leflunomide—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Metipranolol—Anxiety—Leflunomide—systemic scleroderma	0.0044	0.0044	CcSEcCtD
Metipranolol—Tension—Lisinopril—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Metipranolol—Palpitations—Mycophenolic acid—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Metipranolol—Discomfort—Leflunomide—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Metipranolol—Nervousness—Lisinopril—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Metipranolol—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00432	0.00432	CcSEcCtD
Metipranolol—Cough—Mycophenolic acid—systemic scleroderma	0.00431	0.00431	CcSEcCtD
Metipranolol—Rash—Pentoxifylline—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Metipranolol—Hypertension—Mycophenolic acid—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Metipranolol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Metipranolol—Headache—Pentoxifylline—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Metipranolol—Myalgia—Mycophenolic acid—systemic scleroderma	0.00421	0.00421	CcSEcCtD
Metipranolol—Vision blurred—Lisinopril—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Metipranolol—Anxiety—Mycophenolic acid—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Metipranolol—Asthenia—Mometasone—systemic scleroderma	0.00419	0.00419	CcSEcCtD
Metipranolol—Discomfort—Mycophenolic acid—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00408	0.00408	CcSEcCtD
Metipranolol—Oedema—Mycophenolic acid—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Metipranolol—Nausea—Pentoxifylline—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Metipranolol—Palpitations—Lisinopril—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Metipranolol—Cough—Lisinopril—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00385	0.00385	CcSEcCtD
Metipranolol—Tension—Mycophenolate mofetil—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Metipranolol—Myalgia—Lisinopril—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Metipranolol—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Metipranolol—Anxiety—Lisinopril—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Metipranolol—Dyspnoea—Leflunomide—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Metipranolol—Discomfort—Lisinopril—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Metipranolol—Rash—Mometasone—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Metipranolol—Asthenia—Captopril—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Metipranolol—Dermatitis—Mometasone—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Metipranolol—Headache—Mometasone—systemic scleroderma	0.00366	0.00366	CcSEcCtD
Metipranolol—Oedema—Lisinopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Metipranolol—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Metipranolol—Somnolence—Mycophenolic acid—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Metipranolol—Nausea—Mometasone—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Metipranolol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Metipranolol—Cough—Mycophenolate mofetil—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Metipranolol—Dizziness—Captopril—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Metipranolol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Metipranolol—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Metipranolol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Metipranolol—Myocardial infarction—Prednisone—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Metipranolol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Metipranolol—Hypersensitivity—Azathioprine—systemic scleroderma	0.0033	0.0033	CcSEcCtD
Metipranolol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Metipranolol—Dyspnoea—Lisinopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Metipranolol—Rash—Captopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Metipranolol—Dermatitis—Captopril—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Metipranolol—Somnolence—Lisinopril—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Metipranolol—Headache—Captopril—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Metipranolol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Metipranolol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Metipranolol—Bradycardia—Prednisone—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Metipranolol—Nausea—Captopril—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Metipranolol—Asthenia—Leflunomide—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Metipranolol—Dizziness—Azathioprine—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Metipranolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Metipranolol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Metipranolol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Metipranolol—Rash—Azathioprine—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Metipranolol—Dermatitis—Azathioprine—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Metipranolol—Headache—Azathioprine—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Metipranolol—Dizziness—Leflunomide—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Metipranolol—Conjunctivitis—Methotrexate—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Metipranolol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Metipranolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Metipranolol—Epistaxis—Methotrexate—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Metipranolol—Rash—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Metipranolol—Dermatitis—Leflunomide—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Metipranolol—Nausea—Azathioprine—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Metipranolol—Headache—Leflunomide—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Metipranolol—Asthenia—Lisinopril—systemic scleroderma	0.00261	0.00261	CcSEcCtD
Metipranolol—Rash—Mycophenolic acid—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Metipranolol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Metipranolol—Headache—Mycophenolic acid—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Metipranolol—Nausea—Leflunomide—systemic scleroderma	0.00251	0.00251	CcSEcCtD
Metipranolol—Vision blurred—Prednisone—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Metipranolol—Visual impairment—Methotrexate—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Metipranolol—Dizziness—Lisinopril—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Metipranolol—Nausea—Mycophenolic acid—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Metipranolol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Metipranolol—Rash—Lisinopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Metipranolol—Dermatitis—Lisinopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Metipranolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Metipranolol—Hypertension—Prednisone—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Metipranolol—Headache—Lisinopril—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Metipranolol—Myalgia—Prednisone—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Metipranolol—Anxiety—Prednisone—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Metipranolol—Discomfort—Prednisone—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Metipranolol—Nausea—Lisinopril—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Metipranolol—Oedema—Prednisone—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Metipranolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Metipranolol—Vision blurred—Methotrexate—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Metipranolol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Metipranolol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Metipranolol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Metipranolol—Cough—Methotrexate—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Metipranolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Metipranolol—Myalgia—Methotrexate—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Metipranolol—Discomfort—Methotrexate—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Metipranolol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Metipranolol—Dyspnoea—Methotrexate—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Metipranolol—Somnolence—Methotrexate—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Metipranolol—Hypersensitivity—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Metipranolol—Asthenia—Prednisone—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Metipranolol—Dizziness—Prednisone—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Metipranolol—Rash—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Metipranolol—Dermatitis—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Metipranolol—Headache—Prednisone—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Metipranolol—Hypersensitivity—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Metipranolol—Asthenia—Methotrexate—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Metipranolol—Nausea—Prednisone—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Metipranolol—Dizziness—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Metipranolol—Rash—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Metipranolol—Dermatitis—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Metipranolol—Headache—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Metipranolol—Nausea—Methotrexate—systemic scleroderma	0.00107	0.00107	CcSEcCtD
